CVCT 2025: Cleerly Late-Breaking Science Identifies Thresholds of High Plaque Burden in Non-Obstructive CAD that May Carry Greater Risk Than Obstructive Disease

DENVER–(BUSINESS WIRE)–Dec 15, 2025–

Cleerly, a leader in AI-based cardiovascular imaging, presented new, late-breaking science from the international CONFIRM2 Registry at the Global CVCT Scientific Program 2025 in Washington, DC.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215032850/en/…

Story continues

TRENDING NOW

LATEST LOCAL NEWS